Search for content, post, videos

Iconovo signs agreement with Monash University

Johan Wäborg
Iconovo has signed a development agreement with Monash University for the development of inhaled oxytocin in ICOone for maternal health. The agreement verifies the suitability of ICOone for use with innovative pharmaceuticals. Monash University’s Institute of Pharmaceutical Sciences (MIPS) is l
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.